A new study from NBCF-funded scientists at the Garvan Institute of Medical Research has uncovered a possible treatment regime for women with treatment-resistant oestrogen receptor positive (ER+) breast cancer.
Skip to Content Skip to Navigation 
You have returned to the top of the page.
Study guides next generation of advanced breast cancer therapy
